C. Schwartzkopf

Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity

P. McNamara, J. Gromada, S. Commerford, 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly.

B. Dardik, C. Schwartzkopf, R. Chatelain, 2000, Journal of lipid research.

The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system

M. Currie, C. Winrow, Juli E Jones, 2021, Journal of Neuroinflammation.

Beneficial Metabolic Effects of Praliciguat, a Soluble Guanylate Cyclase Stimulator, in a Mouse Diet-Induced Obesity Model

Courtney M. Shea, Emmanuel S. Buys, E. Buys, 2022, Frontiers in Pharmacology.

The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases

M. Currie, C. Winrow, P. Renhowe, 2021, Frontiers in Pharmacology.